Abstract

Population: 9-16 year-old individuals living in dengue endemic areas

Intervention: 3 doses of CYD-TDV administered 6 months apart

Comparison: Placebo

Outcome: Virologically-confirmed dengue occurring > 12 months of completion of 3 doses

GRADE table